Cargando…
Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer’s Disease: Are There Methodological Biases?
Mounting evidence that alterations in brain-derived neurotrophic factor (BDNF) levels and signaling may be involved in the etiopathogenesis of Alzheimer’s disease (AD) has suggested that its blood levels could be used as a biomarker of the disease. However, higher, lower, or unchanged circulating BD...
Autores principales: | Balietti, Marta, Giuli, Cinzia, Conti, Fiorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061178/ https://www.ncbi.nlm.nih.gov/pubmed/29330839 http://dx.doi.org/10.1007/s12035-017-0866-y |
Ejemplares similares
-
Effect of a Cognitive Training Program on the Platelet APP Ratio in Patients with Alzheimer’s Disease
por: Casoli, Tiziana, et al.
Publicado: (2020) -
Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer’s Disease
por: Balietti, Marta, et al.
Publicado: (2017) -
Contribution of non-reference alleles in mtDNA of Alzheimer's disease patients
por: Casoli, Tiziana, et al.
Publicado: (2014) -
Cognitive Stimulation Modulates Platelet Total Phospholipases A(2) Activity in Subjects with Mild Cognitive Impairment
por: Balietti, Marta, et al.
Publicado: (2016) -
Brain-derived neurotrophic factor as biomarker
por: Sookaromdee, Pathum, et al.
Publicado: (2020)